CD8 T cells are associated with a good prognosis only when sufficient numbers of mature DCs are present in the tumor-associated tertiary lymphoid structures (Troy et al., 1998; Teng et al., 2014; Giraldo et al., 2015). The gene discussed is CD8A; the disease is neoplasm.